Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

BACKGROUND: In indolent systemic mastocytosis (ISM), several risk factors of disease progression have been identified. Previous studies, performed with limited patient numbers, have also shown that the clinical course in ISM is stable and comparable to that of cutaneous mastocytosis (CM). The aim of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Allergy
Huvudupphovsmän: Trizuljak, Jakub, Sperr, Wolfgang R., Nekvindová, Lucie, Elberink, Hanneke O., Gleixner, Karoline V., Gorska, Aleksandra, Lange, Magdalena, Hartmann, Karin, Illerhaus, Anja, Bonifacio, Massimiliano, Perkins, Cecelia, Elena, Chiara, Malcovati, Luca, Fortina, Anna B., Shoumariyeh, Khalid, Jawhar, Mohamad, Zanotti, Roberta, Bonadonna, Patrizia, Caroppo, Francesca, Zink, Alexander, Triggiani, Massimo, Parente, Roberta, von Bubnoff, Nikolas, Yavuz, Akif S., Hägglund, Hans, Mattsson, Mattias, Panse, Jens, Jäkel, Nadja, Kilbertus, Alex, Hermine, Olivier, Arock, Michel, Fuchs, David, Sabato, Vito, Brockow, Knut, Bretterklieber, Agnes, Niedoszytko, Marek, van Anrooij, Björn, Reiter, Andreas, Gotlib, Jason, Kluin-Nelemans, Hanneke C., Mayer, Jiri, Doubek, Michael, Valent, Peter
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115854/
https://ncbi.nlm.nih.gov/pubmed/32108361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.14248
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk